Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Breast Neoplasms 43Colorectal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 13Lung Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Melanoma 12Head and Neck Neoplasms 12Pancreatic Neoplasms 11Colonic Neoplasms 11Carcinoma, Renal Cell 11Rectal Neoplasms 10Prostatic Neoplasms 9Carcinoma, Ovarian Epithelial 8Ovarian Neoplasms 7Esophageal Neoplasms 7Breast Neoplasms, Male 7Salivary Gland Neoplasms 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Liver Neoplasms 6Stomach Neoplasms 5Precancerous Conditions 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Lymphoma, Large B-Cell, Diffuse 5Kidney Neoplasms 5Esophageal Squamous Cell Carcinoma 5Breast Carcinoma In Situ 5Adenocarcinoma Of Esophagus 5Uterine Cervical Neoplasms 4

Interventions

Nivolumab 2Gefitinib 2Biopsy 2vandetanib 1linrodostat 1ficlatuzumab 1durvalumab 1X-Rays 1Trioxsalen 1Rhinoplasty 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Phototherapy 1Photochemotherapy 1Pemetrexed 1Optical Imaging 1Methods 1Metformin 1Ipilimumab 1Independent Medical Evaluation 1Immunohistochemistry 1Gemcitabine 1Educational Status 1Dihematoporphyrin Ether 1Cetuximab 1Carboplatin 1CTLA-4 Antigen 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoid Interstitial Pneumonia × Immunohistochemistry × Clear all
NCT01414426 2021-01-14

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

University of Chicago

Phase 2 Completed
20 enrolled 7 charts
Head & NeckOther neoplasm

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡